We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$673B
| $247M | 0.57% |
1,255,840
-85,900
| -6% | -$17.8M |
|
27
AbbVie
ABBV
$455B
| $247M | 0.57% |
1,614,171
-606,900
| -27% | -$92.7M |
|
28
PepsiCo
PEP
$191B
| $240M | 0.55% |
1,439,979
-107,550
| -7% | -$18.1M |
|
29
Costco
COST
$423B
| $221M | 0.51% |
461,577
+43,190
| +10% | +$21.9M |
|
30
Thermo Fisher Scientific
TMO
$214B
| $210M | 0.48% |
387,424
-24,100
| -6% | -$13.3M |
|
31
Verizon
VZ
$193B
| $209M | 0.48% |
4,123,672
+165,000
| +4% | +$8.35M |
|
32
JPMorgan Chase
JPM
$933B
| $209M | 0.48% |
1,856,466
-1,013,200
| -35% | -$126M |
|
33
Walmart Inc
WMT
$884B
| $208M | 0.48% |
5,136,426
+168,237
| +3% | +$7.76M |
|
34
Danaher
DHR
$138B
| $205M | 0.47% |
912,444
+27,523
| +3% | +$6.34M |
|
|
ATVI
35
DELISTED
Activision Blizzard
ATVI
| $199M | 0.46% |
2,554,674
+100,800
| +4% | +$7.84M |
|
|
SIVB
36
DELISTED
SVB Financial Group
SIVB
| $199M | 0.46% |
502,629
+329,451
| +190% | +$155M |
|
37
Abbott
ABT
$183B
| $198M | 0.45% |
1,823,564
-22,900
| -1% | -$2.6M |
|
38
Wells Fargo
WFC
$258B
| $184M | 0.42% |
4,691,496
-35,200
| -0.7% | -$1.54M |
|
39
Comcast
CMCSA
$84B
| $183M | 0.42% |
4,655,859
-68,000
| -1% | -$2.92M |
|
40
GE Aerospace
GE
$368B
| $182M | 0.42% |
4,597,569
+317,932
| +7% | +$15.4M |
|
41
Adobe
ADBE
$98.5B
| $180M | 0.41% |
492,078
+19,500
| +4% | +$7.94M |
|
42
Bank of America
BAC
$433B
| $177M | 0.41% |
5,677,373
-53,900
| -0.9% | -$1.94M |
|
43
Accenture
ACN
$99.9B
| $176M | 0.4% |
634,622
-25,300
| -4% | -$7.6M |
|
44
Broadcom
AVGO
$1.85T
| $173M | 0.4% |
3,552,260
-369,000
| -9% | -$20.7M |
|
45
Salesforce
CRM
$148B
| $171M | 0.39% |
1,034,739
+56,200
| +6% | +$9.93M |
|
46
Cisco
CSCO
$448B
| $170M | 0.39% |
3,976,321
-427,800
| -10% | -$20.5M |
|
47
IBM
IBM
$209B
| $168M | 0.38% |
1,186,690
+315,200
| +36% | +$42.5M |
|
48
Hartford Financial Services
HIG
$39.2B
| $166M | 0.38% |
2,542,532
+617,800
| +32% | +$43.3M |
|
49
Walt Disney
DIS
$167B
| $165M | 0.38% |
1,752,475
-148,650
| -8% | -$16.5M |
|
50
Fortive
FTV
$17.7B
| $161M | 0.37% |
3,937,711
-1,057,043
| -21% | -$46.7M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.